Nav: Home

A muscle protein promotes nerve healing

January 23, 2019

Typically, damaged nerve fibres of the central nervous system (CNS) in the brain, the optic nerve and spinal cord don't have the ability to regenerate. One of the pivotal reasons is that nerve fibres don't produce any proteins that are necessary for their regeneration, or that they don't produce enough of those proteins. The team at the Department for Cell Physiology headed by Professor Dietmar Fischer showed that, under certain conditions, a protein is formed in injured nerve cells of the CNS that had previously only been described in muscle cells. In experiments, the muscle LIM protein promoted the regeneration of damaged nerves. The research team published their article in the journal Cell Reports on 22 January 2019.

No therapy for clinical applications as yet

Injuries or diseases of nerves in the central nervous system result in lifelong disabilities, such as paraplegia caused by a damage to the spinal cord or blindness following the injury of the optic nerve. "Nerve regeneration therapies for clinical applications are not available yet," points out Dietmar Fischer. This is because nerve fibres - so-called axons - either don't produce any proteins that are essential for their regeneration at all, or they don't produce enough of them. "If we identified such proteins and triggered their production using gene therapy, we'd have novel, applicable methods for nerve regeneration at our disposal," says Fischer.

His team took a step towards this goal as they discovered that the muscle LIM protein (MLP), which plays a crucial role in, for example, the heart, is also produced in the nerve cells of the central nervous system under certain conditions.

MLP stabilises structures in growth cones

The scientists demonstrated that the production of MLP in neurons is induced if they had been artificially stimulated to grow nerve fibres. In the process, the protein gathered in the tips of the regrowing fibres where it stabilised the structures in so-called growth cones that play an essential role in regeneration. This was the first evidence that MLP has a physiological role in other tissues than muscle.

If the researchers blocked the protein's function or suppressed its production, the nerve cells' ability to grow axons was significantly reduced. If, conversely, the researchers deployed gene therapy to cause damaged nerve cells to produce MLP, the respective axons showed a significant increase of their regenerative ability. In animals, axon growth in the injured optic nerve was thus considerably boosted when compared to animals that didn't undergo the therapy.

More studies to follow

"At the Department for Cell Physiology, we will continue to study if similar methods may promote the regeneration in other regions of an injured brain or spinal cord resp. after a stroke," concludes Fischer.
-end-


Ruhr-University Bochum

Related Gene Therapy Articles:

Mysterious gene transcripts after cancer therapy
Drugs that are used in cancer therapy to erase epigenetic alterations in cancer cells simultaneously promote the production of countless mysterious gene transcripts, scientists from the German Cancer Research Center now report in Nature Genetics.
Gene therapy could 'turn off' severe allergies
A single treatment giving life-long protection from severe allergies such as asthma could be made possible by immunology research at The University of Queensland.
Lipid nanoparticles for gene therapy
Twenty-five years have passed since the publication of the first work on solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs) as a system for delivering drugs.
New gene therapy for pseudarthrosis trialed at Kazan University
A team headed by Professor Albert Rizvanov, director of the Gene and Cell Technologies Open Lab, created a gene therapy drug that encodes growth factors for the stimulation of blood vessel and bone formation.
WSU researcher develops safer gene therapy
A Washington State University researcher has developed a way to reduce the development of cancer cells that are an infrequent but dangerous byproduct of gene therapy.
New gene therapy prevents muscle wasting associated with cancer
A new gene therapy could be used to prevent the loss of muscle mass and physical strength associated with advanced cancer
On the path to controlled gene therapy
The ability to switch disease-causing genes on and off remains a dream for many physicians, research scientists and patients.
Gene therapy against brain cancer
A team from the International School for Advanced Studies (SISSA) in Trieste has obtained very promising results by applying gene therapy to glioblastoma.
First gene therapy successful against human aging
Elizabeth Parrish, CEO of Bioviva USA Inc. has become the first human being to be successfully rejuvenated by gene therapy, after her own company's experimental therapies reversed 20 years of normal telomere shortening.
Designing gene therapy
Scientists in the Barabas group at EMBL have increased the efficiency of a genome-engineering tool called Sleeping Beauty, which is showing promise in clinical trials for leukemia and lymphoma immunotherapies.

Related Gene Therapy Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Changing The World
What does it take to change the world for the better? This hour, TED speakers explore ideas on activism—what motivates it, why it matters, and how each of us can make a difference. Guests include civil rights activist Ruby Sales, labor leader and civil rights activist Dolores Huerta, author Jeremy Heimans, "craftivist" Sarah Corbett, and designer and futurist Angela Oguntala.
Now Playing: Science for the People

#521 The Curious Life of Krill
Krill may be one of the most abundant forms of life on our planet... but it turns out we don't know that much about them. For a create that underpins a massive ocean ecosystem and lives in our oceans in massive numbers, they're surprisingly difficult to study. We sit down and shine some light on these underappreciated crustaceans with Stephen Nicol, Adjunct Professor at the University of Tasmania, Scientific Advisor to the Association of Responsible Krill Harvesting Companies, and author of the book "The Curious Life of Krill: A Conservation Story from the Bottom of the World".